Early steps in androgen biosynthesis: from cholesterol to DHEA

Area of Science:

• Endocrinology
• Biochemistry
• Genetics

Background:

• Sex steroids, androgens and estrogens, are synthesized from dehydroepiandrosterone (DHEA).
• DHEA biosynthesis from cholesterol involves a multi-step enzymatic pathway.
• Genetic mutations in key regulatory proteins can result in severe clinical conditions.

Purpose of the Study:

• To outline the four-step biosynthesis of DHEA from cholesterol.
• To identify the enzymes and proteins involved in each step of DHEA synthesis.
• To explore the genetic basis of DHEA synthesis defects and their potential link to polycystic ovary syndrome.

Main Methods:

• Review of the established biochemical pathway for DHEA synthesis.
• Analysis of genetic mutations in steroidogenic acute regulatory protein (StAR) and P450c17.
• Examination of enzyme kinetics and regulatory mechanisms of P450c17.

Main Results:

• Cholesterol conversion to DHEA involves StAR, P450scc, and P450c17 (with 17 alpha-hydroxylase and 17,20 lyase activities).
• Mutations in StAR cause congenital lipoid adrenal hyperplasia.
• Mutations in P450scc and its partners are likely incompatible with gestation; isolated 17,20 lyase deficiency is rare but informative.

Conclusions:

• The genetic basis and enzymology of P450c17 are crucial for understanding DHEA regulation in adrenarche.
• Potential involvement of a serine kinase in the pathogenesis of polycystic ovary syndrome is suggested.
• This pathway elucidation is vital for reproductive endocrinology and metabolic disorder research.